Fennec Pharmaceuticals Inc (FENC) — Net Asset Quality Index
Fennec Pharmaceuticals Inc (FENC) has a Net Asset Quality Index of 56.0% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $75.75 Million minus total liabilities of $33.31 Million yields net assets of $42.44 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check cash flow quality index of Fennec Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Fennec Pharmaceuticals Inc Net Asset Quality Index Over Time (1999–2025)
This chart shows how Fennec Pharmaceuticals Inc's Net Asset Quality Index has evolved across 26 annual periods from 1999 to 2025. As of June 2026, the index stands at 56.0%, representing net assets of $42.44 Million against total assets of $75.75 Million USD. See net assets of Fennec Pharmaceuticals Inc for net asset value and shareholders' equity analysis.
Annual Net Asset Quality Index for Fennec Pharmaceuticals Inc (1999–2025)
The table below presents the year-by-year Net Asset Quality Index for Fennec Pharmaceuticals Inc from 1999 to 2025, covering 26 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Fennec Pharmaceuticals Inc (FENC) market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 50.0% | $35.05 Million | $70.07 Million | $35.02 Million | ▲ +63.1 pp |
| 2024 | -13.1% | $-5.87 Million | $44.95 Million | $50.82 Million | ▲ +30.2 pp |
| 2023 | -43.3% | $-11.62 Million | $26.86 Million | $38.49 Million | ▼ -33.7 pp |
| 2022 | -9.5% | $-2.57 Million | $26.94 Million | $29.51 Million | ▼ -79.9 pp |
| 2021 | 70.4% | $15.77 Million | $22.41 Million | $6.64 Million | ▼ -22.2 pp |
| 2020 | 92.5% | $29.07 Million | $31.42 Million | $2.35 Million | ▲ +8.6 pp |
| 2019 | 83.9% | $11.88 Million | $14.15 Million | $2.27 Million | ▼ -8.9 pp |
| 2018 | 92.9% | $21.31 Million | $22.95 Million | $1.64 Million | ▼ -1.3 pp |
| 2017 | 94.2% | $26.76 Million | $28.40 Million | $1.64 Million | ▲ +4.3 pp |
| 2016 | 89.9% | $3.57 Million | $3.97 Million | $402.00K | ▲ +36.1 pp |
| 2015 | 53.8% | $548.00K | $1.02 Million | $471.00K | ▲ +27.9 pp |
| 2014 | 25.8% | $613.00K | $2.37 Million | $1.76 Million | ▲ +108.9 pp |
| 2013 | -83.0% | $-1.46 Million | $1.75 Million | $3.21 Million | ▲ +126.6 pp |
| 2012 | -209.6% | $-4.96 Million | $2.37 Million | $7.32 Million | ▼ -207.4 pp |
| 2011 | -2.2% | $-120.00K | $5.35 Million | $5.47 Million | ▲ +79.9 pp |
| 2010 | -82.2% | $-4.92 Million | $5.99 Million | $10.92 Million | ▼ -130.9 pp |
| 2009 | 48.7% | $406.00K | $833.00K | $427.00K | ▼ -1.6 pp |
| 2008 | 50.4% | $3.05 Million | $6.06 Million | $3.01 Million | ▼ -31.8 pp |
| 2007 | 82.2% | $14.15 Million | $17.21 Million | $3.06 Million | ▲ +36.5 pp |
| 2006 | 45.7% | $7.58 Million | $16.58 Million | $9.00 Million | ▼ -24.8 pp |
| 2005 | 70.5% | $20.06 Million | $28.45 Million | $8.39 Million | ▼ -8.6 pp |
| 2003 | 79.1% | $33.00 Million | $41.73 Million | $8.73 Million | ▲ +19.4 pp |
| 2002 | 59.7% | $15.31 Million | $25.66 Million | $10.35 Million | ▼ -29.5 pp |
| 2001 | 89.2% | $6.08 Million | $6.82 Million | $736.04K | ▼ -4.7 pp |
| 2000 | 93.9% | $9.82 Million | $10.46 Million | $635.41K | ▲ +86.7 pp |
| 1999 | 7.3% | $46.73K | $643.19K | $596.46K | — |